Week In Review: Inventis Closes $70 Million Financing To Develop 30 Novel Therapeutics
March 16, 2019 at 17:22 PM EDT
InventisBio of Shanghai closed a $70 million Series C financing led by Advantech Capital and CMBI, followed by Pudong Innotek. Founded in 2013, InventisBio focuses on discovering and developing novel therapeutics for cancer and metabolic diseases.
